Back
Phathom Pharmaceuticals Vs. Oramed Pharmaceuticals Industry Stock Comparison
Sell
30
PHAT
Phathom Pharmaceuticals
Last Price:
$4.24
Seasonality Move:
10.29%
Sell
39
ORMP
Oramed Pharmaceuticals
Last Price:
$2.36
Seasonality Move:
0.24%
Sell
30
Phathom Pharmaceuticals (PHAT)
is a Sell
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
-
The current Phathom Pharmaceuticals [PHAT] share price is $4.25. The Score for PHAT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
PHAT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Oramed Pharmaceuticals (ORMP)
is a Sell
Is Oramed Pharmaceuticals a Buy, Sell or Hold?
-
The current Oramed Pharmaceuticals [ORMP] share price is $2.34. The Score for ORMP is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
ORMP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $4.25The current trend is relatively stagnant and PHAT is experiencing buying pressure, which is a positive indicator for future bullish movement.
ORMP Stock Price Chart
What is Oramed Pharmaceuticals's stock price today?
-
The Oramed Pharmaceuticals share price today is $2.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORMP is experiencing slight selling pressure.
PHAT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 54.82 | Buy |
Chaikin Money Flow: | 716455 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.93 - 4.33) | Buy |
Bollinger Bands (100): | (3.92 - 6.52) | Sell |
ORMP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 61.79 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.16 - 2.3) | Buy |
Bollinger Bands (100): | (2.14 - 2.38) | Buy |
PHAT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.16 | Buy |
20-day SMA: | 3.53 | Buy |
50-day SMA: | 4.38 | Sell |
200-day SMA: | 9.44 | Sell |
8-day EMA: | 4.11 | Buy |
20-day EMA: | 3.93 | Buy |
50-day EMA: | 4.34 | Sell |
200-day EMA: | 7.48 | Sell |
ORMP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.18 | Buy |
20-day SMA: | 2.21 | Buy |
50-day SMA: | 2.22 | Buy |
200-day SMA: | 2.32 | Buy |
8-day EMA: | 2.21 | Buy |
20-day EMA: | 2.21 | Buy |
50-day EMA: | 2.23 | Buy |
200-day EMA: | 2.34 | Buy |
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.92 per share, an increase next quarter of $0.37 per share, an increase this year of $1.80 per share, and an increase next year of $2.44 per share.
Oramed Pharmaceuticals Earnings Growth & ORMP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.43 per share, and a decrease next year of $0.00 per share.
Phathom Pharmaceuticals Technical Analysis
May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Oramed Pharmaceuticals Technical Analysis
May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |